Skip to main content

Table 2 A summary of the follow-up characteristics of the GSTT-AS cohort

From: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database

Characteristics

Frequency (n = 788)

No. of years on AS

 Mean (±SD)

4.7 (±3.06)

 Median (IQR)

4.3 (2.5–6.5)

Number of follow-up biopsies per person

n (%)

 0

160 (20.3)

 1

361 (45.8)

 2

210 (26.7)

  > 3

57 (7.2)

Median time to first follow-up biopsy

Months (95% CI)

 Biopsy follow up time

13 (11.6–16.7)

Median time to first follow-up biopsy by diagnostic method

Months (95% CI)

 TP

26 (25–27)

 TRUS

6 (5–8)

 Other

8 (4–20)

Number of follow-up MRIs per person

n (%)

 0

237 (30.1)

 1

297 (37.7)

 2

153 (19.4)

  > 3

101 (12.8)

Median time to first follow-up MRI

Months (95% CI)

 MRI follow up time

45 (37–53)

Median time to first follow-up MRI by diagnostic method

Months (95% CI)

 TP

52 (33–60)

 TRUS

43 (36–53)

 Other

28 (6–63)

  1. AS active surveillance, TP trans-perineal, TRUS trans-rectal ultrasound, MRI magnetic resonance imaging, SD standard deviation, IQR interquartile range